CA2318199A1 - Platelet adp receptor inhibitors - Google Patents

Platelet adp receptor inhibitors Download PDF

Info

Publication number
CA2318199A1
CA2318199A1 CA002318199A CA2318199A CA2318199A1 CA 2318199 A1 CA2318199 A1 CA 2318199A1 CA 002318199 A CA002318199 A CA 002318199A CA 2318199 A CA2318199 A CA 2318199A CA 2318199 A1 CA2318199 A1 CA 2318199A1
Authority
CA
Canada
Prior art keywords
alkylamino
compound
nitrogen
alkyl
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002318199A
Other languages
English (en)
French (fr)
Inventor
Alan M. Laibelman
Hans-Michael Jantzen
Pamela B. Conley
Larry J. Fretto
Robert M. Scarborough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COR Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2318199A1 publication Critical patent/CA2318199A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002318199A 1998-01-15 1999-01-08 Platelet adp receptor inhibitors Abandoned CA2318199A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US753798A 1998-01-15 1998-01-15
US9210998P 1998-01-15 1998-01-15
US60/092,109 1998-01-15
US09/007,537 1998-01-15
PCT/US1999/000518 WO1999036425A1 (en) 1998-01-15 1999-01-08 Platelet adp receptor inhibitors

Publications (1)

Publication Number Publication Date
CA2318199A1 true CA2318199A1 (en) 1999-07-22

Family

ID=26677116

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002318199A Abandoned CA2318199A1 (en) 1998-01-15 1999-01-08 Platelet adp receptor inhibitors

Country Status (5)

Country Link
EP (1) EP1047699A1 (ja)
JP (1) JP2002509152A (ja)
AU (1) AU2219599A (ja)
CA (1) CA2318199A1 (ja)
WO (1) WO1999036425A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110194777A (zh) * 2018-02-26 2019-09-03 香港科技大学 一种离子型聚集诱导发光团及其制备方法和应用

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6906063B2 (en) 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
JP4574100B2 (ja) * 2000-02-04 2010-11-04 ポートラ ファーマシューティカルズ， インコーポレイテッド 血小板ａｄｐレセプターインヒビター
AU2001264566A1 (en) * 2000-05-05 2001-11-20 Cor Therapeutics, Inc. Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
ATE490568T1 (de) 2001-11-29 2010-12-15 Ube Industries Polymerelektrolytzusammensetzung
DE602004024093D1 (de) 2003-10-03 2009-12-24 Portola Pharm Inc 2,4-dioxo-3-chinazolinylarylsulfonylharnstoffe
MXPA06003625A (es) 2003-10-03 2006-08-11 Portola Pharm Inc Isoquinolinonas sustituidas.
US7550499B2 (en) * 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
KR20070064356A (ko) 2004-09-29 2007-06-20 포톨라 파마슈티컬스, 인코포레이티드 치환된 2ｈ-1,3-벤족사진-4(3ｈ)온
EP2362473B1 (en) 2005-03-04 2012-10-24 Ube Industries, Ltd. Producion method for polymer electrolyte
EP2428514A1 (en) 2005-11-03 2012-03-14 Portola Pharmaceuticals, Inc. [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
CN107158385B (zh) * 2016-03-14 2020-07-14 苏州大学 Rip3抑制剂在制备抗血小板血栓药物中的用途
CN113959912B (zh) * 2020-07-20 2024-06-21 深圳迈瑞生物医疗电子股份有限公司 抗血小板聚集干扰的白细胞检测方法、试剂及其应用
CN113959911B (zh) * 2020-07-20 2024-06-18 深圳迈瑞生物医疗电子股份有限公司 抗血小板聚集干扰的检测方法、试剂及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110194777A (zh) * 2018-02-26 2019-09-03 香港科技大学 一种离子型聚集诱导发光团及其制备方法和应用
CN110194777B (zh) * 2018-02-26 2022-02-11 香港科技大学 一种离子型聚集诱导发光团及其制备方法和应用

Also Published As

Publication number Publication date
AU2219599A (en) 1999-08-02
EP1047699A1 (en) 2000-11-02
JP2002509152A (ja) 2002-03-26
WO1999036425A1 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
RU2379300C2 (ru) Ингибиторы gsk-3
EP1257550B1 (en) Platelet adp receptor inhibitors
EP1417196B1 (en) Dna-pk inhibitors
AU2005292314B2 (en) Substituted 2H-1,3-benzoxazin-4(3H)-ones
EP1668002B1 (en) 2,4-dioxo-3-quinazolinylaryl sulfonylureas
CA2318199A1 (en) Platelet adp receptor inhibitors
KR101457339B1 (ko) 아랄킬 치환된 피페리딘 또는 피페라진 유도체 및 정신분열증 치료를 위한 이의 용도
JP4865785B2 (ja) Ｃｄｋ阻害剤としての置換１，５−ナフチリジンアゾリジノン
TW202345847A (zh) 多環化合物
JP2008529995A (ja) Ａｔｍ阻害剤
CN115232126B (zh) 一种β-卡波林-1,2,3-三唑化合物及其制备方法与抗阿尔兹海默病的应用
JPS60218377A (ja) ４−フエニルフタラジン誘導体及びそれを有効成分とする循環改善剤
WO2005068458A2 (en) Five-membered heterocyclic compounds as inhibitors of src family protein kinase
EP4371981A1 (en) Sulfur/phosphorus-containing aryl compound and application thereof
US6667306B1 (en) Platelet ADP receptor inhibitors
CN1809581A (zh) 含烷胺基烷氧基取代的糖碳甙异黄酮化合物及其制法和用途
MXPA00006946A (en) Platelet adp receptor inhibitors
US6153634A (en) 4,5-azolo-oxindoles
RU2827867C1 (ru) Пиримидин- и азотсодержащее бициклическое соединение
CN110950773B (zh) 联苯二酚酰胺衍生物及其作为抗癌药物的应用
WO2024131882A1 (zh) 一种吡啶多取代化合物的盐型、晶型及其制备方法
Goldstein et al. C59 Inhibitor

Legal Events

Date Code Title Description
FZDE Dead